2024 Meeting

Purdue Memorial Union, Purdue University

West Lafayette, Indiana
May 2 and 3, 2024
Meeting Booklet

Thursday, May 2nd

Check in, Coffee, Poster Setup, and Sponsor Booth Setup, 10:00 AM

Welcome, 11:00 AM

Review of Structural Approaches to Drug Metabolism Studies, 11:10 AM
Eric Johnson, Ph.D., Professor Emeritus, Dept. of Molecular Medicine, Scripps Research, La Jolla, CA.

Biochemical and Biophysical Studies of Cytochrome P450s and Transporters, 11:50 AM
William Atkins, Ph.D., Professor and Chair, Dept. of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA.

Lunch, Students and Postdocs Network with Industry Scientists, View Posters, and Visit Sponsor Booths, 12:30 PM

Interindividual Variability in Tyrosine Kinase Inhibitor Metabolism in Ethnically Diverse Populations, 2:00 PM
Klarissa Jackson, Ph.D., Assistant Professor, Division of Pharmacotherapy & Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.

Drug Transporters in Chemotherapy-Induced Neuropathy, 2:40 PM
Shuiying Hu, Ph.D., Assistant Professor, Division of Outcomes & Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH.

Break, 3:20 PM

DESI-MS Application in Drug Discovery and Development of an Automated High-Throughput Drug Discovery Mass Spectrometry Platform, 3:40 PM
Graham Cooks, Ph.D., Henry B. Hass Distinguished Professor, Dept. of Chemistry, Purdue University, West Lafayette, IN.

Proteomics-Based Research in Non-P450 Enzymes and Transporters, 4:20 PM
Bhagwat Prasad, Ph.D., Associate Professor, Dept. of Pharmaceutical Sciences, Washington State University, Spokane, WA.

Poster Session (Author Available), Sponsor Booths, and Mixer, 5:00 PM
Authors at odd numbered posters (5:00-6:00 PM). Authors at even numbered posters (6:00-7:00 PM).

Dinner, 7:30 PM

Friday, May 3rd

GLDMDG Business Meeting, 7:30 AM

Continental Breakfast, Poster Viewing and Sponsor Booth Setup, 7:30 AM

Vendor Presentations, 8:00 AM

• Improving Throughput of Bioanalytical Research through Advancements in QQQ Technology, and Expansion of Multi-omic Panels for Targeted Analysis of Biomarkers
  John Sausen, B.S., M.B.A., Director of Strategic Initiatives - Mass Spectrometry, Agilent Technologies

• Cyclic Ion Mobility - High Resolution Mass Spectrometry for the Rapid Profiling of Drug Metabolites in Biofluids
  Iggy Kass, Ph.D., HRMS Business Development Executive, Waters Corporation

• Plateable Hepatocytes in Non-Small Molecule Drug Development
  Christopher Bohl, Ph.D., Senior Manager Technical Support, BioIVT

ADME of RNA-Based Therapy, 9:00 AM
Julie Lade, Ph.D., Scientific Associate Director, Pharmacokinetics & Drug Metabolism, Amgen.

Leveraging In Silico ADME Modeling in Drug Discovery – A Learning Journey, 9:40 AM
Stella Doktor, M.S., Principal Research Scientist, AbbVie, North Chicago, IL.

Break, 10:20 AM

ADME Bioanalytical Strategies and Workflows to Quantify and Evaluate Oligonucleotide Therapeutics, 10:40 AM
Ryan Hill, B.S., Principal Research Scientist, ADME Drug Disposition, Lilly, Indianapolis, IN.

The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain, 11:20 AM
Hannah Wilkins, B.S., The Johns Hopkins University School of Medicine, Baltimore, MD, Student Abstract Award Winner.

A Physiologically Relevant Intestinal Model for Mechanistic Assessment of Oral Bioavailability, 11:35 AM
Agnes Badu-Mensah, Ph.D., Eli Lilly and Company, Indianapolis, IN, Postdoc Abstract Award Winner.

Closing Remarks, 11:50 AM